Photronics IncPLAB

Photronics Inc reported quarterly revenue of $209.9 million for the six months ending May 3, 2026, down from $209.5 million in the same period the year before, while net income rose to $31.4 million from a $4.1 million loss. The company’s operating income improved to $42.2 million, and cash generated from operations clocked in at $144.3 million. The cash pile swelled to $511.5 million, with short-term investments adding another $126.2 million-enough to fund 17 quarters of R&D at today’s run-rate. (source: PLAB 10-Q (2026-06-11), https://www.sec.gov/Archives/edgar/data/810136/000114036126024915/ef20070467_10q.htm)

Photronics makes photomasks-precision glass plates that act as stencils for etching circuits onto silicon wafers-serving both integrated-circuit and flat-panel-display customers. The company sells access to MaskLink™, a password-protected extranet that lets customers check order status, but the real product is still a six-figure glass plate that takes weeks to ship. The polished brochures talk up “innovative solutions,” yet the balance sheet quietly reveals that $28.6 million of the latest quarter’s revenue came from a single related party-nearly 14% of sales. (source: PLAB 10-Q (2026-06-11), https://www.sec.gov/Archives/edgar/data/810136/000114036126024915/ef20070467_10q.htm)

The numbers in the 10-Q are clear: total assets of $1.93 billion, liabilities of $237.4 million, and shareholders’ equity of $1.24 billion. Research and development spend was a modest $2.8 million for the six months, while capital expenditure totalled $93.4 million, funding capacity upgrades rather than moonshots. Inventories rose by $6.2 million to $67.8 million, a line item that rarely draws applause but keeps the lights on in a fab where every misplaced micron costs money. Diluted EPS came in at $0.54 on 58.7 million weighted shares-numbers that won’t set any records but do keep the listing fee paid. (source: PLAB 10-Q (2026-06-11), https://www.sec.gov/Archives/edgar/data/810136/000114036126024915/ef20070467_10q.htm)

For those tracking the company’s disclosure cadence, the May 28, 2026 8-K announced second-quarter fiscal 2026 results and scheduled a follow-up conference call, while the June 2 Form SD filed the obligatory conflict-minerals disclosure under Rule 13p-1. The July 14 Schedule 13G/A showed a beneficial owner reduced its position to 5.2% from 6.1%, a move that passed unremarked except by the filing robot itself. There are no earnings surprises, no product launches, and no regulatory drama-just a steady industrial business ticking over. (sources: PLAB 8-K (2026-05-28), https://www.sec.gov/Archives/edgar/data/810136/000114036126023057/ef20074970_8k.htm; PLAB SD (2026-06-02), https://www.sec.gov/Archives/edgar/data/810136/000114036126023696/ef20075426_sd.htm; PLAB SCHEDULE 13G/A (2026-07-14), https://www.sec.gov/Archives/edgar/data/810136/000035420426000849/xslSCHEDULE_13G_X02/primary_doc.xml)

The company’s own service pages confirm that MaskLink™ is the digital shop window into order status, while the integrated-circuits and flat-panel-display service pages repeat the same pitch without adding fresh data. The disclosure trail is complete on EDGAR, but the product rail offers no new orders, no capacity milestones, and no customer wins-just the same password-protected view of the same factory queue. (sources: https://www.photronics.com/integrated-circuits-ic/our-services/; https://www.photronics.com/flat-panel-displays-fpd/our-services/)

If you’re hunting for chart context, the SEC filings do not supply price levels, and the company’s own investor materials stop short of drawing trendlines. All that can be said is that the stock is listed in the US under CIK 810136, where it trades with the liquidity typical of a small-cap industrial that does not flash red or green on CNBC. (source: PLAB SEC submissions JSON (2026-07-25), https://data.sec.gov/submissions/CIK0000810136.json)

The weight of evidence shows an industrial supplier quietly compounding cash while servicing a narrow customer base via an extranet that is useful but not transformative. The tension sits in the related-party revenue slice, the modest R&D budget, and the absence of any visible catalyst beyond routine capacity upgrades and the next quarterly filing. (source: PLAB 10-Q (2026-06-11), https://www.sec.gov/Archives/edgar/data/810136/000114036126024915/ef20070467_10q.htm)